Publicaciones en colaboración con investigadores/as de Centro de Investigación Biomédica en Red sobre Enfermedades Hepáticas y Digestivas (13)

2022

  1. Long-Term Outcome of Critically Ill Advanced Cancer Patients Managed in an Intermediate Care Unit

    Journal of Clinical Medicine, Vol. 11, Núm. 12, pp. 3472

2021

  1. Aging in Male Wistar Rats Associates with Changes in Intestinal Microbiota, Gut Structure, and Cholecystokinin-Mediated Gut-Brain Axis Function

    Journals of Gerontology - Series A Biological Sciences and Medical Sciences, Vol. 76, Núm. 11, pp. 1915-1921

  2. Gallbladder disease and pancreatic cancer risk: a multicentric case-control European study

    European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP), Vol. 30, Núm. 6, pp. 423-430

  3. The role of bronchoscopy in patients with sars-cov-2 pneumonia

    ERJ Open Research, Vol. 7, Núm. 3

2020

  1. Liver–lung interactions in acute respiratory distress syndrome

    Intensive Care Medicine Experimental , Vol. 8

2016

  1. Urine metabolome profiling of immune-mediated inflammatory diseases

    BMC Medicine, Vol. 14, Núm. 1

2012

  1. Surface Expression and Subunit Specific Control of Steady Protein Levels by the Kv7.2 Helix A-B Linker

    PLoS ONE, Vol. 7, Núm. 10

2011

  1. Outcome of patients following hepatic resection for metastatic cutaneous and ocular melanoma

    Journal of Hepato-Biliary-Pancreatic Sciences, Vol. 18, Núm. 2, pp. 268-275

2010

  1. Incidence of liver cirrhosis in HIV-infected patients with chronic hepatitis B or C in the era of highly active antiretroviral therapy

    Antiviral Therapy, Vol. 15, Núm. 6, pp. 881-886

  2. Mice lacking thyroid hormone receptor β show enhanced apoptosis and delayed liver commitment for proliferation after partial hepatectomy

    PLoS ONE, Vol. 5, Núm. 1

2009

  1. Rate and timing of hepatitis c virus relapse after a successful course of pegylated interferon plus ribavirin in hiv-infected and hiv-uninfected patients

    Clinical Infectious Diseases, Vol. 49, Núm. 9, pp. 1397-1401

2008

  1. Emerging drugs for hepatitis C

    Expert Opinion on Emerging Drugs, Vol. 13, Núm. 1, pp. 1-19

  2. Hepatitis B virus genotype A2 harbours an L217R polymorphism which may account for a lower response to adefovir

    Journal of Antimicrobial Chemotherapy